Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Dean

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Experimental Cell Research|August 1, 1989
Instability of extrachromosomal cosmid DNA in SV40-transformed human (ataxia-telangiectasia) cellsS W Dean, L Kincla, H R Sykes, et al.
Cancer Research|September 15, 1988
Re: Impaired glutathione biosynthesis in cultured ataxia-telangiectasia cellsS W Dean, H R Sykes, J Cole, et al.
Mutagenesis|September 4, 1999
Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagensS W Dean, T M Brooks, B Burlinson, et al.
Mutation Research|July 1, 1994
Genotoxicity studies with chloroethaneR Ebert, N Fedtke, H Certa, et al.
Mutagenesis|May 1, 1992
Development of assays for the detection of photomutagenicity of chemicals during exposure to UV light. II. Results of testing three sunscreen ingredientsS W Dean, R H Dunmore, S P Ruddock, et al.
Mutagenesis|September 1, 1991
Development of assays for the detection of photomutagenicity of chemicals during exposure to UV light--I. Assay developmentS W Dean, M Lane, R H Dunmore, et al.
Mutation Research|October 16, 1999
Mutagenicity of 4-nitroquinoline 1-oxide in the MutaMouseM Nakajima, M Kikuchi, K Saeki, et al.
Mutation Research|June 1, 1994
Recommendations for the performance of UDS tests in vitro and in vivoS Madle, S W Dean, U Andrae, et al.
Gene|June 15, 1988
SV 40-transformed normal and DNA-repair-deficient human fibroblasts can be transfected with high frequency but retain only limited amounts of integrated DNAL V Mayne, T Jones, S W Dean, et al.
Anti-Cancer Drug Design|November 1, 1986
Cellular pharmacology of mu-[1,2-bis(diphenylphosphino)ethane]bis[(1-thio-beta-D-gluco pyranosato-S)gold(I)]: a novel antitumor agentC K Mirabelli, B D Jensen, M R Mattern, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Experimental Cell Research|August 1, 1989
Instability of extrachromosomal cosmid DNA in SV40-transformed human (ataxia-telangiectasia) cellsS W Dean, L Kincla, H R Sykes, et al.
Cancer Research|September 15, 1988
Re: Impaired glutathione biosynthesis in cultured ataxia-telangiectasia cellsS W Dean, H R Sykes, J Cole, et al.
Mutagenesis|September 4, 1999
Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagensS W Dean, T M Brooks, B Burlinson, et al.
Mutation Research|July 1, 1994
Genotoxicity studies with chloroethaneR Ebert, N Fedtke, H Certa, et al.
Mutagenesis|May 1, 1992
Development of assays for the detection of photomutagenicity of chemicals during exposure to UV light. II. Results of testing three sunscreen ingredientsS W Dean, R H Dunmore, S P Ruddock, et al.
Mutagenesis|September 1, 1991
Development of assays for the detection of photomutagenicity of chemicals during exposure to UV light--I. Assay developmentS W Dean, M Lane, R H Dunmore, et al.
Mutation Research|October 16, 1999
Mutagenicity of 4-nitroquinoline 1-oxide in the MutaMouseM Nakajima, M Kikuchi, K Saeki, et al.
Mutation Research|June 1, 1994
Recommendations for the performance of UDS tests in vitro and in vivoS Madle, S W Dean, U Andrae, et al.
Gene|June 15, 1988
SV 40-transformed normal and DNA-repair-deficient human fibroblasts can be transfected with high frequency but retain only limited amounts of integrated DNAL V Mayne, T Jones, S W Dean, et al.
Anti-Cancer Drug Design|November 1, 1986
Cellular pharmacology of mu-[1,2-bis(diphenylphosphino)ethane]bis[(1-thio-beta-D-gluco pyranosato-S)gold(I)]: a novel antitumor agentC K Mirabelli, B D Jensen, M R Mattern, et al.
Pageof 3